Genesis Healthcare (NYSE:GEN) Posts Quarterly Earnings Results, Beats Expectations By $0.49 EPS

Genesis Healthcare (NYSE:GEN) released its quarterly earnings data on Thursday. The company reported $0.40 EPS for the quarter, beating the consensus estimate of ($0.09) by $0.49, Fidelity Earnings reports. The business had revenue of $1.12 billion during the quarter, compared to analysts’ expectations of $1.13 billion.

Shares of GEN stock traded up $0.04 during trading hours on Friday, hitting $1.54. The company’s stock had a trading volume of 250,507 shares, compared to its average volume of 214,777. The company has a 50 day moving average of $1.31 and a 200 day moving average of $1.23. The stock has a market cap of $230.69 million, a PE ratio of -0.99 and a beta of 0.93. Genesis Healthcare has a 12-month low of $0.92 and a 12-month high of $1.74.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Featured Article: What type of investment options does a Roth IRA provide?

Earnings History for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.